CAP Cancer Protocol Bresast Invasive
Standardized Pathology Report for Breast Cancer
Inmunohistochemical approach to define tumor type
Genomic and phenotypic heterogeneity in prostate cancer | Nature Reviews Urology
Frontiers | Effects of Transcranial Direct Current Stimulation and High- Definition Transcranial Direct Current Stimulation Enhanced Motor Learning on Robotic Transcranial Magnetic Stimulation Motor Maps in Children
Multifocality, Multicentricity, and Bilaterality of Breast Cancer | IntechOpen
Tumor focality in prostate cancer: implications for focal therapy | Nature Reviews Clinical Oncology
IJMS | Free Full-Text | The Journey of Cancer Cells to the Brain: Challenges and Opportunities
Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study | PLOS ONE
Grading of Multifocal Prostate Cancer Cases in which the Largest Volume and the Highest Grade Do Not Coincide within One Lesion | Journal of Urology
Tumor size and focality in breast carcinoma: Analysis of concordance between radiological imaging modalities and pathological examination at a cancer center - ScienceDirect
Tumor Size, Not Small Vessel Invasion, Predicts Survival in Patients With Hepatocellular Carcinoma - بست لاب للتجهيزات المعملية
Definition of carcinoma in situ - NCI Dictionary of Cancer Terms - NCI
Definition of Synoptic Reporting
Confluence Mobile - SNOMED Confluence
Cancers | Free Full-Text | A miRNA-Based Prognostic Model to Trace Thyroid Cancer Recurrence
Tumor size and focality in breast carcinoma: Analysis of concordance between radiological imaging modalities and pathological examination at a cancer center - ScienceDirect
Surveillance Intensity in Intermediate Risk, Nonmuscle Invasive Bladder Cancer: Revisiting the Optimal Timing and Frequency of Cystoscopy | Journal of Urology
Definition of Synoptic Reporting The CAP has developed this list of
Radiofrequency Tumor Ablation
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? - The Lancet Oncology
